Silexion Therapeutics Corp Announces Warrant Inducement Offer

SEC Filing 8-K (0001178913-25-002570)

On July 31, 2025, Silexion Therapeutics Corp entered into an inducement offer letter agreement with certain holders of its existing warrants. The agreement allows holders to exercise their warrants at a reduced exercise price of $11.57 per share in exchange for new warrants to purchase up to 304,212 ordinary shares at an exercise price of $11.32 per share. The company expects to receive approximately $1.8 million in gross proceeds from the exercise of the existing warrants. The new warrants will be exercisable upon shareholder approval of an increase in the company's authorized share capital and will have a 24-month term. The company has engaged H.C. Wainwright & Co., LLC as the exclusive placement agent for the transaction. The proceeds from the transaction will be used for general corporate purposes.